Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Express Scripts
AstraZeneca
Julphar
Baxter
Colorcon
Chinese Patent Office
Medtronic
McKesson

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202103

« Back to Dashboard

NDA 202103 describes DASATINIB, which is a drug marketed by Apotex Inc and is included in one NDA. Additional details are available on the DASATINIB profile page.

The generic ingredient in DASATINIB is dasatinib. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dasatinib profile page.
Summary for 202103
Tradename:DASATINIB
Applicant:Apotex Inc
Ingredient:dasatinib
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 202103

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Jun 10, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jun 10, 2016TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength70MG
Approval Date:Jun 10, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Merck
Queensland Health
Covington
Deloitte
US Department of Justice
Colorcon
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.